XLVvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with XLV, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/22/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV ETF 2 | +6.19%– | +9.37%– | +3.84%– | +21.40%– | +23.25%– | +33.00%– |
| Flows | XLV ETF 2 | +$1.12B– | -$467M– | +$943M– | +$2.38B– | -$5.28B– | +$3.47B– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV ETF 2 | +18.37%– | +15.76%– | +14.31%– | +14.97%– |
| Max drawdown | XLV ETF 2 | -3.83%– | -10.51%– | -17.05%– | -17.05%– |
| Max drawdown duration | XLV ETF 2 | 15d– | 116d– | 444d– | 444d– |
Trading data
XLV | ETF 2 | |
Last sale 7/24/2026 at 1:30 PM | $162.57 | – |
| Previous close 07/23/2026 | $161.44 | – |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLV | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
XLV | ETF 2 | |
|---|---|---|
| Last price | $162.57 | – |
| 1D performance | +0.70% | – |
| AuM | $41.69 B | – |
| E/R | 0.08% | – |
Characteristics
XLV | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | State Street Investment Management | – |
| Benchmark | S&P Health Care Select Sector Index | – |
| N° of holdings | 59 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
XLV
USA
97.92%
Other
2.08%
ETF 2
Sectors
XLV
Healthcare
97.73%
Other
2.27%
ETF 2
Advertisement
Diversification
XLV
Total weight of top 15 holdings out of 15
72.82%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
